Novo Nordisk's 20%+ price drop since yesterday following a significant downgrade in sales and profit guidance is a great buying opportunity. The stock's forward P/E is at half the stock's five-year av...We’re a leader in voice technology in the UK and globally. We work with companies big and small to cater for any complex voice calling needs.Novo